“US scientists have succeeded in genetically editing the immune systems of three cancer patients using CRISPR, without creating any side effects, a first for the tool which is revolutionizing biomedical research.
The highly anticipated results from the first phase of a clinical trial were published in the journal Science on Thursday…”
